Citius Pharmaceuticals Inc (CTXR) stock is lower by -27.62% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CTXR stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 5. CTXR's rank also includes a long-term technical score of 27. CTXR has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CTXR!